• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 21 Mar

    Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million

    RESEARCH TRIANGLE PARK, N.C., March 21, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (“Opus” or the “Company”) (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other ophthalmic disorders, today announced the pricing of an underwritten public offering… Read More..

    Share this:
  • 21 Mar

    DRYWORLD Launches Marketing Campaign To Showcase New Graduated Compression Line In Official Partnership With New Zealand Super Rugby

    SANTA BARBARA, CA, March 21, 2025 – PRISM MediaWire – Today DRYWORLD Brands Inc. (OTC PINK: IBGR), a leading performance athletic brand, has announced the debut of its “Innovation that Elevates” campaign which introduces its new revolutionary graduated compression apparel designed to enhance the performance of elite athletes. The launch… Read More..

    Share this:
  • 18 Mar

    Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025

    IRVINE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that it will report fourth quarter 2024 financial results after the market closes on Monday, March 24, 2025. Oncocyte will host a live Zoom webinar to discuss the company's financial results… Read More..

    Share this:
« Previous 1 … 31 32 33 34 35 … 253 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact